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Development of a quantification method based on isotopic variants of O-methyl isourea
(OMIU) in conjunction with reversed-phase (RP) liquid chromatography (LC) electrospray
mass spectrometry is described for determining the relative quantification of -related peptides
Ac-VQIVXK-NH2. Extracted ion chromatograms of the mass spectrometric data derived from
online microcapillary LC separation identifies the retention times of the isotopically derivat-
ized peptides together with their ion abundances. Data-dependent MSMS analysis of both
derivatized variants of the same peptide provides a complementary method for identification
and resolution between isobaric species. In addition, with respect to offline LCMALDI a larger
number of analogues are detected and formation of amyloid is also observed for the aspartic
acid and histidine-containing peptides. (J Am Soc Mass Spectrom 2007, 18, 201–207) © 2007
American Society for Mass SpectrometryDefining cellular dynamics in terms of changes inprotein expression levels means it is no longersufficient to simply qualitatively identify pro-
teins; instead, methods for protein quantification are
required. Relative protein quantification relies largely
on the use of differential stable isotope labeling [1, 2].
This strategy can be achieved in vivo, by metabolic
labeling of proteins by cell growth in the presence of
isotopically labeled amino acids [3], or in vitro by
chemical derivatization of the proteins or their corre-
sponding proteolysis products. In both cases the pro-
teins or peptides that are to be compared are labeled
separately with isotopic variants of a specific com-
pound. The mixtures containing isotopically derivat-
ized peptides are then recombined before mass spectro-
metric (MS) analysis. Relative quantification is
determined by the ratio of the ion abundances of the
two derivatized peptide ions under comparison. In vivo
metabolic labeling involves the growth of a given cell
population in a medium containing the natural form of
an essential amino acid, whereas the other cell popula-
tion is grown in a medium containing the heavy isoto-
pic variant of this amino acid, such as leucine versus
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doi:10.1016/j.jasms.2006.09.015deuterated leucine (Leu-d3) [4, 5] or arginine versus
deuterated arginine (13C6-Arg) [6, 7].
A number of methods have been developed for the
selective derivatization of functional groups within
proteins/peptides using isotopic variants of a given
chemical reagent. The first major application of this
strategy involved the derivatization of cysteine residues
with isotopic variants of the ICAT, a reagent composed
of an affinity tag (biotin) separated by a polyether linker
from the reactive moiety [8, 9]. Alternative postdiges-
tion isotopic labeling techniques include selective deri-
vatization of carboxylic acids [10] and primary amines
[11–13]. However, these chemical reactions suffer from
the large number of reaction sites present in the mac-
romolecule. A far easier reaction to control is the
guanidination of lysine residues based on the use of
O-methyl isourea (OMIU) [14 –17]. Development of a
quantification method based on isotopic variants of
OMIU was recently proposed in conjunction with
reversed-phase (RP) liquid chromatography (LC) and
matrix-assisted laser desorption ionization (MALDI)
mass spectrometry (MS) [18]. This derivatization strat-
egy, termed guanidino labeling derivatization (GLaD),
has been successfully used for the relative quantifica-
tion of -related peptides using an offline LC technique
combined with MALDI ToF analysis [19].
Tau is a microtubule-associated protein that controls a
range of microtubule-associated functions. In Tau the
formation of amyloid, an insoluble protein deposit, has
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202 BERESZCZAC ET AL. J Am Soc Mass Spectrom 2007, 18, 201–207been associated with Alzheimer’s disease. The propensity
of Tau to form amyloid has been correlated with the
presence of the nucleating sequence VQIVYK. This se-
quence has been found to seed amyloid formation and
control the rate of its formation [20]. To investigate how
variations in the amino acid sequence of this nucleating
peptide affect the formation of amyloid, a peptide library
of Ac-VQIVXK-NH2 (X  naturally occurring l-amino
acids with the exception of Cys and Leu) was generated
and physical properties were measured [19]. In the
MALDI-based method, relative abundances of differen-
tially labeled peptide analogues were determined to mea-
sure the partitioning between soluble and insoluble forms
in a solution containing the mixture of mutated peptides.
Here, we implement the GLaD strategy in combination
with an online LC-based method coupled to a micro
electrospray hybrid quadrupole ion trap (IT) time-of-flight
(ToF) mass spectrometer (Scheme 1). Rapid determination
of the abundance ratios together with data-dependent
tandem mass spectrometric (MSMS) analysis produces a
faster and more robust methodology for the relative
quantification and partition coefficient determination of
-related peptides between two different phases.
Experimental
Materials
N-Acetyl peptide amides with the sequence Ac-VQIVXK-
NH2, where X is one of 19 naturally occurring l-amino
acids with the exception of cysteine and leucine, were
prepared using synthetic solid-phase peptide procedures
as previously described [18]. All solvents were HPLC
Scheme 1. Schematic illustrating the methodo
mutated peptides between two different phasesgrade and were purchased from Rathburn Chemicals(Walkerburn, Scotland, UK). Both isotopic variants of
O-methyl isourea (OMIU) were prepared according to
previously published procedures using urea (1 g; Fluka,
Buchs SG, Switzerland) or 15N-urea (1 g; Cambridge
Isotope Laboratories, Andover, MA). The product identity
was confirmed using 1H-NMR.
Guanidination of Lysine Residues
in Peptide Mutants
Amyloid formation was carried out by suspension of 5.3
mg of the mutated peptide mixture in 1.5 mL 20 mM
MOPS containing 0.01% NaN3 at pH 7.2 for 4–5 days at
room temperature. After centrifugation, the supernatant
and pellet fractions were modified with OMIU. Lyophi-
lized samples were dissolved in 300 L of 50:50
hexafluoro-2-propanol (HFIP):H2O and stirred for 2 h to
allow formation of the monomeric species in solution. To
the supernatant fraction 10 mg of 14N-OMIU was added
and to the pellet fraction 15N-OMIUwas added. Diisopro-
pylethylamine (DIEA, 50 L) was also added to each
solution and stirred overnight. Both fractions were subse-
quently evaporated using a nitrogen stream. The fractions
were then recombined and lyophilized before LCMS anal-
ysis.
Liquid Chromatography
Reversed-phase capillary HPLC was used to separate
the mixture of mutated peptides. Components of the
mixture were separated using a C18 PepMap 100 col-
umn [300 m (id)  15 cm; LC Packings, Amsterdam,
used for the relative quantification of -related
IU  O-methyl isourea).logyThe Netherlands] and a solvent gradient with mobile
lysin
203J Am Soc Mass Spectrom 2007, 18, 201–207 GLaD WITH ONLINE-LC ON A HYBRID IT ToFphase compositions of 5% acetonitrile containing 0.1%
(vol/vol) formic acid for the aqueous phase and 80%
acetonitrile containing 0.1% (vol/vol) formic acid for
the organic phase. LC-10ADVP HPLC pumps (Shi-
madzu Corporation, Kyoto, Japan) were used to deliver
solvent at a flow rate of 100 L/min. A postcolumn
split was used to reduce the flow to an estimated 8
L/min. The composition of B was increased linearly
for 20 to 22 min from 0 to 40%. The sample was loaded
into a 5 L injection loop using a six-port rheodyne
Figure 1. (a) Total ion chromatogram (TIC) f
isotopically derivatized mutated peptide mixtur
min identifying the presence of all singly cha
Accumulated mass spectrum from 10.0 to 12.
isotopically derivatized arginine-containing andvalve (VICI Valco Instruments Co., Houston, TX).Mass Spectrometry
All MS data were acquired on the LCMS-IT-ToF (Shi-
madzu). Electrosprayed ions were generated using a cap-
illary voltage of 4.66 kV. A curved desolvation line (CDL)
held at a temperature of 230 °C was used to aid desolva-
tion. Nitrogen was pumped into the ion source at a rate of
1.5 L/min to help nebulization of the electrospray solu-
tion. A heat block temperature of 250 °C was also used.
Ions are extracted from the ion source and subsequently
e online reversed-phase LC separation of the
Accumulated mass spectrum from 10.0 to 17.4
isotopically derivatized mutated peptides. (c)
n identifying the presence of doubly charged
e-containing peptides.or th
e. (b)
rged
3 mifocused by the Q-array device, before axial injection into
ing a
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applied to the ion trap. Once trapped the ions are cooled
using argon from a pulse valve. The ToF mass analyzer
was used to acquire data in both MS andMSMSmodes of
operation. InMSmode a 50ms ion accumulation timewas
used before ion trapping. Ions are cooled for 20 ms before
ion ejection into the ToF mass analyzer. Before MSMS
analysis precursor ions can be isolated using the filtered
noise field (FNF) method, which generates a notched
broadband signal composed of frequency components.
The FNF is applied to the electrodes of the ion trap,
causing the resonant ejection of all unwanted ions. In
MSMS mode the ion accumulation time corresponds to
Figure 2. (a) and (b) Extracted ion chromatog
observed in both the supernatant [derivatized
[derivatized with “heavy” (H) version of OMIU].
of elution (13.7–16.4 min) of the mutated peptid
substituted amino acid at the point of mutation i
peptide derivatized with the “heavy” version of
doubly charged species for the histidine-contain100 ms. The window used for precursor ion isolationcorresponds to a width of 3 Th and precursor ion isolation
time of 50 ms. To induce fragmentation of the precursor
ion, resonant excitation is induced by the application of a
supplementary AC potential to the end-cap electrodes.
For collision-induced dissociation (CID), argon is used as
a collision gas. CID was carried out over 30 ms and using
a q value of 0.251 (45 kHz). For data-dependent MSMS
precursor selection criteria included a charge-state filter
selecting only1 and2 species and amonoisotopic filter
to ensure selection of only the monoisotopic ions for
MSMS analysis. Three scans were accumulated in each
MSMS spectrum. In both MS and MSMS mode data were
acquired over a mass range of 200–2000 Th. In both
for isotopically derivatized mutated peptides
“light” (L) version of OMIU] and as amyloid
ccumulated mass spectrum over the time period
at were observed in both phases (b and c). The
cated in the spectrum, where the  identifies the
U. The inset displays both differentially labeled
nalogue.rams
with
(c) A
es th
s indi
OMIregimes of operation ions are pulsed into the ToF with an
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1.65 kV.
Results and Discussion
To generate amyloid, all mutated peptides were added
to a solution of 20 mMMOPS containing 0.01% NaN3 at
pH 7.2. Generally, formation of amyloid is observed
over a period of 5 days. After centrifugation the pep-
tides present in the amyloid pellet were treated with a
solution containing the “heavy” version of OMIU,
whereas those in the supernatant were labeled with the
“light” version of OMIU. The two solutions were re-
combined and subjected to an online microcapillary LC
separation before analysis on a hybrid quadrupole ion
trap time-of-flight mass spectrometer. As previously
described for the MALDI analysis of the unfractionated
peptide mixture [19], overlap among ions belonging to
peptides differing by a few Daltons leads to difficulties
in determining the correct ion abundance ratios. Frac-
tionation of the peptide mixture using offline reversed-
phase LC in conjunction with automated sample spot-
ting onto a MALDI target plate has proved its utility in
discriminating between different species. Starting from
these premises, an online fractionation approach was
implemented here, thus allowing continuous infusion
into the mass spectrometer. Figure 1a shows the total
ion chromatogram (TIC) resulting from a 20 min gradi-
ent LC separation. As indicated in Figure 1b, all mu-
tated peptides were eluted between 10 and 17.5 min.
The mass spectrum obtained by accumulating all scans
over this time period is displayed in Figure 2a and
identifies the presence of all singly charged mutated
peptide ions. No traces of the unmodified peptides
were observed, suggesting that the guanidination went
Table 1. Theoretical m/z corresponding to derivatized
mutated peptides
Residue change m/z Light Heavy
A 1 740.5 742.5
D 1 784.49 786.49
E 1 798.5 800.5
F 1 816.53 818.53
G 1 726.48 728.48
H 2 403.76 404.76
I 1 782.54 784.54
Ka 2 420.28 421.28
M 1 800.52 802.52
N 1 783.50 785.50
P 1 766.51 768.51
Q 1 797.52 799.52
R 2 413.28 414.28
S 1 756.49 758.49
T 1 770.51 772.51
V 1 768.53 770.53
W 1 855.54 857.54
Y 1 832.52 834.52
m/z of observed ions are italicized.
aBoth K derivatized.to completion [15]. All singly charged peptide ionsderiving from the derivatization with the “light” ver-
sion of OMIU are present in the spectrum. Only in a few
cases shown in Table 1 is the corresponding heavy
isotopomer observed. Interestingly, the majority of the
peptide ions were detected as singly charged species
with the exception of lysine-, histidine-, and arginine-
containing peptides that were observed solely as dou-
bly charged ions (Figure 1c). This behavior may be
attributable to the presence of two basic residues on
which protonation is highly favored [21]. Additionally,
it should be noted that in the case of the lysine contain-
ing peptide, derivatization with the “light” version of
OMIU has occurred on both lysine residues.
Extracted ion chromatograms of the resulting mass
spectrometric data identify the retention times of the
isotopically derivatized mutated peptides together with
their abundances. Figure 2a and b show the extracted
ion chromatograms for all mutated peptides observed
in both the supernatant and the amyloid pellet. Table 2
summarizes the data of the isotopically derivatized
mutated peptides that were observed. As it can be seen
in Table 3, peptides containing differing amino acids at
the mutation site have different retention times, thus
allowing for the separation of isobaric peptides based
on their hydrophobicity properties. Thus, resolution of
the “light” version of the tyrosine containing peptide at
m/z at 770.5 Th, from the “heavy” version of the
valine-containing peptide that is isobaric, was achieved.
Figure 2a and b also indicate the coelution of both
isotopic variants for the observed mutated peptides
(valine, isoleucine, phenylalanine, tyrosine, methionine,
tryptophan, histidine, glutamic acid, and aspartic acid).
Accumulation of the MS data over the time period
during which the peptides are eluted leads to the
accumulated mass spectrum (Figure 2c) that clearly
identifies the presence of both isotopic variants. Inte-
gration of the extracted ion chromatograms for the
isotopic variants of a given mutated peptide provides a
method of quantification between the soluble and in-
soluble phases and, in addition, a measure of the
partition coefficient. Table 2 details the partition coeffi-
cients for all mutated peptides observed in the amyloid
state.
An additional advantage of the GLaD method
consists of discriminating different mutated peptides
Table 2. Partition coefficients for all mutated peptides
observed in the amyloid state
Peptide L:H
VQIVFK 3.85
VQIVIK 6.60
VQIVVK 3.42
VQIVWK 1.66
VQIVYK 11.02
VQIVMK 0.81
VQIVHK 0.45
VQIVDK 1.62
VQIVEK 0.48
heav
206 BERESZCZAC ET AL. J Am Soc Mass Spectrom 2007, 18, 201–207or isotopic variants of a mutated peptide by data-
dependent MSMS analysis. Figure 3a and b show the
MSMS spectra for data-dependent MSMS analysis of
m/z 768.5 and 770.5, respectively, corresponding to
both isotopic variants of valine-containing peptide.
The data clearly indicate that the sequence similarity
between the isotopic variants is reflected in the m/z of
the b-type ions. However, because the derivatization
occurs on the lysine residue at the C-terminus the
presence of any y-type ions discriminates between
Figure 3. Data-dependent MSMS analysis for: (
peptide derivatized with the “light” version
valine-containing peptide derivatized with the “
Figure 4. Data-dependent MSMS analysis for
peptide derivatized with the “light” version of OMIUisotopic variants for a mutated peptide precursor ion.
Thus, the presence of y2 –y4 ions in Figure 3b of the
“heavy” derivatized valine-containing peptide con-
firms the identity of this ion. In the majority of all
data-dependent experiments the MSMS data confirm
the identity of the peptide ions. Figure 4 shows the
MSMS spectra of the “light” derivatized tyrosine-
containing peptide at m/z 770.5. This ion is isobaric to
the “heavy” derivatized valine-containing peptide
displayed in Figure 3b. Discrimination between the
z 768.51, corresponding to the valine-containing
MIU; (b) m/z 770.51, corresponding to the
y” version of OMIU.
70.50, corresponding to the tyrosine-containinga) m/
of Om/z 7
.
207J Am Soc Mass Spectrom 2007, 18, 201–207 GLaD WITH ONLINE-LC ON A HYBRID IT ToFtwo species is achieved by the presence of the b5 ion
at m/z 583.330.
Conclusions
The use of GLaD in conjunction with online-LC leads to
a vast improvement in analysis times. Unlike the
offline-LC method implemented in combination with
automated sample spotting onto a MALDI target plate,
where a large number of sample spots must be ana-
lyzed, online-LC electrospray (ES) obliterates this prob-
lem because each mutated peptide is eluted directly
into the mass spectrometer, thus reducing the analysis
time. Contemporaneously, the limit of detection also
increases with respect to the LCMALDI experiment
[19], the data clearly indicate that formation of amyloid
is also observed for the aspartic acid and histidine-
containing peptides. This is explained by the intrinsic
nature of the separation process. Whereas in offline
LCMALDI the peptides eluted are mixed with the
matrix in at least three sample spots, decreasing the
amount of analyte present in each individual spot, in
online LCMS the peptide eluted is analyzed continu-
ously in the mass spectrometer, increasing the overall
sensitivity of analysis. Interestingly, the direct compar-
ison between the ESI and MALDI indicate that the
partition coefficients are in accordance, showing mini-
mal variations in response between the two ionization
techniques. The critical point in data-dependent LCMSMS
tandem analysis is the possibility of performing MSMS
on both differentially labeled precursor ions, providing
a complementary method for identification and resolu-
tion between isobaric species. Together with the relative
abundance of both ion pairs, the use of reversed-phase
LC in conjunction with ES provides a direct measure of
Table 3. Reversed-phase LC retention times for mutated
peptides. The amino acid at the point of mutation are indicated.
Substituted amino acid Retention time (min)
His 10.66
Arg 10.97
Lys 11.08
Asn 12.50
Gln 12.86
Gly 12.90
Ser 12.98
Pro 13.23
Asp 13.23
Thr 13.33
Ala 13.33
Glu 13.64
Val 14.10
Tyr 14.25
Ile 14.96
Met 15.03
Phe 15.96
Trp 15.98the hydrophobicities of the peptides under investiga-tion. Finally the method presented can be used in
principle for quantifying proteins in comparative pro-
teomics-type experiments.
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